---
layout: use-case-detail
title: "References — UC-050: Autonomous Adverse Event Report Processing in Pharmacovigilance"
uc_id: "UC-050"
uc_title: "Autonomous Adverse Event Report Processing in Pharmacovigilance"
detail_type: "references"
detail_title: "References"
category: "Industry-Specific"
status: "detailed"
slug: "uc-050-pharma-adverse-event-processing"
permalink: /use-cases/uc-050-pharma-adverse-event-processing/references/
---

## Research Brief

| ID | Resource | Type | What It Covers |
|----|----------|------|----------------|
| `UC` | UC-050 research brief | Local source | Problem statement, constraints, success criteria, and operating assumptions used for scenario calculations |

---

## Case Studies

| ID | Company / Project | Industry | Relevance |
|----|-------------------|----------|-----------|
| `CS1` | Pfizer pilot: "Automation of pharmaceutical safety case processing with artificial intelligence and robotic process automation" | Pharmaceutical | Peer-reviewed feasibility study for AI-assisted case extraction and case-validity classification in PV intake |
| `CS2` | Tech Mahindra: "AI Agents Transforming Case Intake in Pharmacovigilance" | Life sciences services | Public multi-agent case-intake architecture with published throughput, timeliness, and cost metrics |
| `CS3` | ArisGlobal: Advanced Intake powered by LifeSphere NavaX | Life sciences software | Public intake benchmark claiming up to 65% efficiency gains and 90% extraction accuracy |
| `CS4` | ArisGlobal: NavaX Agents Suite expansion | Life sciences software | Public evidence that vendors are moving toward multi-agent suites for regulated work |
| `CS5` | ArisGlobal: NavaX Translation with TransPerfect Life Sciences | Life sciences software | Public evidence that translation is being isolated as a dedicated AI workflow in PV operations |

---

## Technical Documentation

| ID | Resource | Type | What It Covers |
|----|----------|------|----------------|
| `TD1` | Azure OpenAI structured outputs | Official docs | Strict JSON schema outputs, Pydantic parsing, and function-calling constraints |
| `TD2` | LangGraph Graph API overview | Official docs | `StateGraph`, stateful routing, and graph-based orchestration patterns |
| `TD3` | LangGraph interrupts | Official docs | Human-in-the-loop pauses, checkpointing, and resume patterns |
| `TD4` | Semantic Kernel plugins | Official docs | Plugin/function design, tool-count guidance, and enterprise-oriented tool encapsulation |
| `TD5` | Semantic Kernel ChatCompletionAgent | Official docs | Agent composition and plugin-backed agent patterns |
| `TD6` | Microsoft Foundry agents function calling | Official docs | Function-tool definitions, SDK patterns, and managed Azure agent alternatives |

---

## Safety-System and Standards References

| ID | Resource | Type | What It Covers |
|----|----------|------|----------------|
| `INT1` | Veeva Vault API v15 | Official docs | Object-record CRUD, attachments, lifecycle actions, and security model |
| `INT2` | Configure Your Vault for the Intake Inbox Item API | Official docs | Intake inbox API seam for feeding source reports into Vault Safety |
| `INT3` | Veeva Safety ICH E2B(R3) Mapping | Official docs | Mapping of case data into outbound ICH E2B(R3) XML |
| `INT4` | Veeva Safety E2B validation and inbox references | Official docs | Automatic XSD validation and related intake / transmission flow anchors |

---

## Code Repositories & Examples

| ID | Repository | Language | What It Demonstrates |
|----|------------|----------|----------------------|
| `EX1` | LangGraph | Python | Open-source graph orchestration runtime used for the workflow design |
| `EX2` | Semantic Kernel | Python / .NET / Java | Open-source agent and plugin framework used as an Azure-oriented alternative |
| `EX3` | Azure AI Agents Java SDK samples | Java | Official examples for function-calling loops with Microsoft Foundry agents |
| `EX4` | Azure .NET function-calling sample | C# | Official sample linked from Microsoft Foundry function-calling docs |

---

## Notes on Evidence Quality

| Note | Meaning |
|------|---------|
| Vendor metrics (`CS2`-`CS5`) | Useful for architecture and directional ROI, but still vendor-reported. Validate locally before treating them as acceptance criteria. |
| Peer-reviewed metric (`CS1`) | Stronger evidence for technical feasibility, but it is a pilot rather than a production KPI report. |
| Scenario calculations in the other documents | Derived from `UC` plus the public percentage improvements in `CS2` and `CS3`; intentionally labeled `estimated`. |
